Empagliflozin (oral): clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
8
Conditions studied
1
US states with sites
2
Countries
Phase breakdown
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Albuminuria | 1 |
| HIV | 1 |
| HIV (Human Immunodeficiency Virus) | 1 |
| Metabolic Syndrome | 1 |
| Obesity | 1 |
| Obesity & Overweight | 1 |
| Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) | 1 |
| Sickle cell disease | 1 |
Recruiting trials involving Empagliflozin (oral)
- Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
- Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Common questions
How many recruiting trials involve Empagliflozin (oral)?
2 recruiting trials across 8 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.